The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:

ConditionPreterm Labor

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorUniversity of Roma La Sapienza

About this trial

The aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).

Eligibility criteria

Qualifiers

Signed informed consent

Disqualifiers

Fetal structural anomalies

Trial design

Treatments tested in this trial

Magnesium-PEA-HMW Hyaluronic Acid-Vitamin B6-Vitamin D + Vaginal Progesterone
Standard Treatment (Guideline-Based)

Treatment groups

150 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University of Roma La Sapienza

Lead sponsor

Source ClinicalTrials.gov